Assessment of Nutritional Status and Role of Insulin-like Growth Factor-1 in Children

Many studies done on children with thalassemia have shown a variable prevalence of defective IGF-I concentrations have been shown to be low in the majority of children, with or without GH deficiency. The Aim of this study to assess nutritional status and role of Insulin-like growth factor 1 (IGF-1) and its associating factors in children with thalassemia major

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Thalassemia Anemia Anemia, Hemolytic Anemia, Hemolytic, Congenital Congenital, Hereditary, and Neonatal Diseases and Abnormalities Genetic Diseases, Inborn Hematologic Diseases Hemic and Lymphatic Diseases Hemoglobinopathies

Age range

1 year–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Samar Abd El-Hameed

Shibīn al Kawm, Egypt

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Children in the age group of 2-18 years with confirmed diagnosis of Beta thalassemia major.

Exclusion criteria

Children with other chronic diseases (cardiac, renal, vascular)
Children with malignancy

Treatment and study plan

Primary outcomes

IGF-1

Time frame: at the time of recruitment

insulin-like growth factor-1 which measured by enzyme linked immunosorbent assay (ELISA).

Sponsors and collaborators

Lead sponsor

Menoufia University

Other

Registry information

Official study title

Assessment of Nutritional Status and Role of Insulin-like Growth Factor-1 in Children With Thalassemia Major

Important dates

Study start: 2020
Primary completion: 2021
Study completion: 2021
First posted: Sep 7, 2022
Registry last updated: Sep 7, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed